CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,975 | -40.9% | 61,331 | +3.7% | 0.00% | – |
| Q2 2023 | $70,981 | -35.5% | 59,151 | -3.8% | 0.00% | -100.0% |
| Q1 2022 | $110,000 | +18.3% | 61,512 | +1.9% | 0.00% | – |
| Q4 2021 | $93,000 | -26.2% | 60,346 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $126,000 | -43.0% | 62,151 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $221,000 | – | 63,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Bridge Compliance, LLC | 154,130 | $105,487 | 0.03% |
| CHELSEA COUNSEL CO | 81,300 | $55,642 | 0.03% |
| Inspire Advisors, LLC | 186,410 | $127,579 | 0.02% |
| Horst & Graben Wealth Management LLC | 75,722 | $51,824 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 198,492 | $136 | 0.01% |
| Arkadios Wealth Advisors | 100,000 | $68,440 | 0.01% |
| Miller Investment Management, LP | 50,000 | $34,220 | 0.01% |
| XTX Topco Ltd | 29,077 | $19,900 | 0.00% |
| Measured Wealth Private Client Group, LLC | 10,000 | $6,844 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $7,504 | 0.00% |